Characterisation of the Novel HLA‐DRB5*02:02:05 Allele by Sequencing‐Based Typing
HLA · 2024
DOI: 10.1111/tan.15752 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Lucie Blandin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Alleles, Histocompatibility Testing, Exons, Sequence Analysis, DNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐DRB5*02:02:05 differs from HLA‐DRB5*02:02:01 by one nucleotide substitution in codon 134 in exon 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
- Clermont-Auvergne University, EA7453 CHELTER, Clermont-Ferrand, France.
- CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
ORCID-Profile: Marine Cargou, Richard Lemal, Paul Rouzaire
Zitieren
APA
Blandin, L., Ralazamahaleo, M., Cargou, M., Lemal, R., & Rouzaire, P. (2024). Characterisation of the Novel HLA‐DRB5*02:02:05 Allele by Sequencing‐Based Typing. HLA. https://doi.org/10.1111/tan.15752
Vancouver
Blandin L, Ralazamahaleo M, Cargou M, Lemal R, Rouzaire P. Characterisation of the Novel HLA‐DRB5*02:02:05 Allele by Sequencing‐Based Typing. HLA. 2024. doi:10.1111/tan.15752
BibTeX
@article{Blandin2024,
author = {Blandin, Lucie and Ralazamahaleo, Mamy and Cargou, Marine and Lemal, Richard and Rouzaire, Paul},
title = {Characterisation of the Novel HLA‐DRB5*02:02:05 Allele by Sequencing‐Based Typing},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15752}
}
EUVIMED